Company · CIK 0001727196 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Scholar Rock Holding Corp · SRRK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 GForm 4 → | Sep 25, 4:12 pm EDT | Keith WoodsChief Operating Officer | 48,034 | — | — | 572,021 | — | |
| Sep 21, 2026 GForm 4 → | Sep 23, 4:36 pm EDT | David HallalChief Executive Officer, Director | 36,652 | — | — | 1,602,382 | — | |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Jeffrey S. FlierDirector | 3,053 | $53.88 | $164,490 | 27,856 | −9.88% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Michael GilmanDirector | 2,544 | $53.87 | $137,058 | 59,511 | −4.10% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Kristina BurowDirector | 3,053 | $53.74 | $164,064 | 114,657 | −2.59% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Joshua ReedDirector | 3,053 | $53.74 | $164,067 | 19,518 | −13.5% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:30 pm EDT | Katie PengDirector | 5,446 | $53.88 | $293,405 | 34,301 | −13.7% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.